Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KLRA will decline by -2.01% over the next 2 Weeks and hit $16.21 by Monday, September 7, 2026. In that time frame, KLRA's share price is expected to range between $15.22 and $17.17.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 7, 2026 | 15.22 | 16.21 | 17.17 |
| Sep 4, 2026 | 15.41 | 16.26 | 17.13 |
| Sep 3, 2026 | 15.31 | 16.11 | 16.88 |
| Sep 2, 2026 | 15.77 | 16.45 | 17.14 |
| Sep 1, 2026 | 15.86 | 16.46 | 17.07 |
| Aug 31, 2026 | 15.97 | 16.52 | 17.11 |
| Aug 28, 2026 | 16.07 | 16.57 | 17.05 |
| Aug 27, 2026 | 15.96 | 16.43 | 16.87 |
| Aug 26, 2026 | 16.29 | 16.76 | 17.25 |
| Aug 25, 2026 | 16.34 | 16.77 | 17.19 |
KLRA shares rose +7.32% in Tuesday, August 25, 2026's trading session, rising from a previous close of $16.54 to move at $17.75. The stock demonstrated notable intraday movement (see KLRA's key stats for a full breakdown), fluctuating between $16.54 and $18.18, a +9.92% trading range. While recent weeks have seen some volatility, KLRA has managed to secure a -4.52% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.32M shares changing hands, 774.38K more than the previous session. This amounted to $23.50M in total market activity.
Will KLRA Continue Its Downward Trend?
According to analyst ratings and projections for KLRA, Kailera Therapeutics, Inc. shares are anticipated to decrease by -3.36%, potentially reaching $17.17 per share by September 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for KLRA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the KLRA stock forecast, now is not the best time to buy KLRA stock because its current trading price is +9.51% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KLRA covering social and institutional perspectives.
KLRA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KLRA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.63% to 48.41%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 43.45%, suggests a neutral medium-term outlook. Insights into KLRA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Kailera Therapeutics Short-Term Forecasts
KLRA Forecast For Next 5 Days
Our algorithm anticipates Kailera Therapeutics (KLRA) stock could hit $16.76 by Sep 01, 2026. This represents a -5.60% fall from today's price, following a - change over the past five days.
KLRA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Kailera Therapeutics, Inc. (KLRA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $14.99, which would mean a -15.55% decrease from the current price of $17.75. Projections for this period range from a high of $18.52 to a low of $11.95.
KLRA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Kailera Therapeutics's price over the next three months point to a rise. KLRA stock is expected to peak at $96.96 on Sep 21, 2026 after potentially dipping to $16.15 on Aug 25, 2026. On average, KLRA is likely to trade around $45.54 in the coming 90 days.
Kailera Therapeutics Stock Forecast 2025
Based on our predictive models, Kailera Therapeutics (KLRA) is expected to trade between $16.15 and $96.96 throughout 2026. This would result in an average price of $42.62, potentially offering investors a +140.11% return from current levels.
Kailera Therapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Kailera Therapeutics, Inc. (KLRA) is positioned to show a strong performance in August 2026. The price is predicted to move between $16.15 and $20.84, settling at an average of $17.42. This could translate to a -1.86% loss.
September 2026
Based on current market signals, Kailera Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $22.48 to $96.96, with a likely average price of $66.13. Investors could expect a potential return of +272.56%.
October 2026
Our predictive algorithms indicate Kailera Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $35.67–$53.42, with an average target of $39.12. This represents a positive outlook and a possible gain of +120.39%.
November 2026
Analyzing established trends, Kailera Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $34.43 and $38.02, averaging around $36.26. This suggests a +104.28% gain from current levels.
December 2026
Market indicators suggest Kailera Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $32.52 to $38.29, with a midpoint forecast of $34.78. The stock might deliver a +95.94% gain.
January 2027
Forecasting for January 2027, models estimate that Kailera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $32.44 and $39.07, averaging $34.28. This signals a positive trajectory with potential returns around +93.13%.
February 2027
According to our latest forecast models, Kailera Therapeutics, Inc. (KLRA) is positioned to show a strong performance in February 2027. The price is predicted to move between $47.15 and $113.90, settling at an average of $86.80. This could translate to a +389.01% gain.
March 2027
Based on current market signals, Kailera Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $51.88 to $66.05, with a likely average price of $55.10. Investors could expect a potential return of +210.42%.
April 2027
Our predictive algorithms indicate Kailera Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $50.63–$54.40, with an average target of $52.61. This represents a positive outlook and a possible gain of +196.39%.
May 2027
Analyzing established trends, Kailera Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $48.67 and $54.37, averaging around $50.71. This suggests a +185.69% gain from current levels.
June 2027
Market indicators suggest Kailera Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $48.62 to $60.50, with a midpoint forecast of $51.04. The stock might deliver a +187.55% gain.
July 2027
Forecasting for July 2027, models estimate that Kailera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $63.33 and $129.62, averaging $101.54. This signals a positive trajectory with potential returns around +472.06%.
August 2027
According to our latest forecast models, Kailera Therapeutics, Inc. (KLRA) is positioned to show a strong performance in August 2027. The price is predicted to move between $68.07 and $73.32, settling at an average of $70.05. This could translate to a +294.65% gain.
KLRA's history of dividends and stock splits also plays a role in long-term investor confidence.

